Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update

Cover of Publication
Available for download only.

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

Publication ID:

SKU:
SMA16-4938

Publication Date:

3/2016

Format:

Last Updated: 11/07/2018